← Back
Data updated: Mar 10, 2026
GE HEALTHCARE
Infectious DiseaseNeurologyCardiovascular
GE HEALTHCARE is a specialty pharmaceutical company focused on Infectious Disease, Neurology, Cardiovascular. Key products include VIZAMYL.
1951
Since
57
Drugs
-
Trials
20
Approved (2yr)
Key Drugs
Recent Activity
CLARISCAN 2025-12-15
Labeling
CLARISCAN 2025-12-15
Labeling
CLARISCAN 2025-12-15
Labeling
CLARISCAN 2025-12-15
Labeling
THALLOUS CHLORIDE TL 201 2025-12-10
Labeling
VIZAMYL 2025-06-23
Efficacy
VIZAMYL 2025-06-10
Labeling
OPTISON 2025-05-09
Efficacy
TECHNETIUM TC-99M PENTETATE KIT 2025-03-26
OMNISCAN 2025-03-05
Labeling
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Infectious Disease 28%
3 drugs
Neurology 25%
1 drugs Phase 3: 2 Phase 2: 1
Cardiovascular 20%
1 drugs Phase 3: 1 Phase 2: 1 Phase 1: 1
Oncology 17%
1 drugs Phase 2: 1 Phase 1: 3
Respiratory 9%
1 drugs
Pipeline Strength Pro
Loading...
Competitors Pro
GSK big-pharma
Infectious Disease, Respiratory, Oncology, Neurology
Novartis big-pharma
Oncology, Cardiovascular, Respiratory
Merck big-pharma
Oncology, Infectious Disease, Cardiovascular
Novo Nordisk big-pharma
Oncology, Cardiovascular, Infectious Disease, Neurology
Baxter specialty
Infectious Disease, Cardiovascular, Oncology
Active (20)
Discontinued (37)
OMNIPAQUE 240 OMNIPAQUE 210 OMNIPAQUE 70 REGADENOSON VISIPAQUE 270 GALLIUM CITRATE GA 67 DRYTEC INDICLOR MPI DMSA KIDNEY REAGENT ISOPAQUE 280 TECHNETIUM TC 99M MPI MDP HYPAQUE HYPAQUE-CYSTO TECHNETIUM TC 99M SULFUR COLLOID TECHNETIUM TC 99M DIPHOSPHONATE-TIN KIT MPI STANNOUS DIPHOSPHONATE SODIUM POLYPHOSPHATE-TIN KIT HYPAQUE-76 HYPAQUE SODIUM 20% NEOSCAN BILOPAQUE DICOPAC KIT HYPAQUE-M,90% HYPAQUE-M,75% TELEPAQUE AMIPAQUE SODIUM PERTECHNETATE TC 99M TECHNETIUM TC 99M TSC AMERSCAN MDP KIT MPI KRYPTON 81M GENERATOR XENON XE 133-V.S.S. NEPHROFLOW SELENOMETHIONINE SE 75 CINTICHEM TECHNETIUM 99M HEDSPA ISOPAQUE 440 MPI DTPA KIT - CHELATE FLUORINE F-18
Company Info
- First Approval
- 1951-07-16
- Latest
- 2025-12-15
- Applications
- 50